<<
>>

DISEASE RISK ANALYSIS

Although the principal cause of death for most Austral­ian native mammals undergoing CT is failure to ade­quately address threatening processes such as predation by introduced predators (Winnard and Coulson 2008; Clarke 2011; Moseby et al.

2011; Clayton et al. 2014; Tag­gart et al. 2015), disease has the potential to significantly affect the success of native mammal CT programs (Wool­ford et al. 2009; Sharp et al. 2010). The low genetic diver­sity of some endangered native mammals, such as the Tasmanian devil, potentially makes them more suscepti­ble to disease (Wait et al. 2017). A comprehensive disease risk analysis (DRA) is therefore recommended. Readers are referred to Chapter 3 in this volume and several recent reviews for detailed approaches to conducting DRAs in CT programs (Ewen et al. 2012; Sainsbury and Vaughan- Higgins 2012; Jakob-Hoff et al. 2014; Ewen et al. 2015; Hartley and Sainsbury 2017). Tables 2.2-2.7 outline dis­eases that may warrant consideration during DRAs for major taxonomic groups of native mammals for which CTs are most commonly undertaken.

4.

<< | >>
Source: Vogelnest L., Portas T. (Eds.). Current Therapy in Medicine of Australian Mammals. CSIRO,2025. — 848 p.. 2025

More on the topic DISEASE RISK ANALYSIS: